Evidence map›Paper›PMID 38212285›Full record

ArticleCerebral cortex (New York, N.Y. : 1991)2024

Dynamic multilayer functional connectivity detects preclinical and clinical Alzheimer's disease.

Anna Canal-Garcia, Dániel Veréb, Mite Mijalkov, Eric Westman, Giovanni Volpe, Joana B Pereira, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Cerebral cortex (New York, N.Y. : 1991), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Elevation in network dynamics amplifies amyloid-dependent tau pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Neurometabolic and vascular dysfunction as an early diagnostic for Alzheimer's disease and related dementias.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna Canal-GarciaDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm 17165, Sweden.ORCID 0000-0001-7460-741X
Dániel VerébDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm 17165, Sweden.
Mite MijalkovDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm 17165, Sweden.ORCID 0000-0002-9844-4413
Eric WestmanDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm 17165, Sweden.
Giovanni VolpeDepartment of Physics, University of Gothenburg, Gothenburg 40530, Sweden.
Joana B PereiraDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm 17165, Sweden.
Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Alzheimer's AssociationNIA NIH HHS U01 AG024904NIBIB NIH HHSNIH HHS U01 AG024904
6 · The paper itself

Abstract

Increasing evidence suggests that patients with Alzheimer's disease present alterations in functional connectivity but previous results have not always been consistent. One of the reasons that may account for this inconsistency is the lack of consideration of temporal dynamics. To address this limitation, here we studied the dynamic modular organization on resting-state functional magnetic resonance imaging across different stages of Alzheimer's disease using a novel multilayer brain network approach. Participants from preclinical and clinical Alzheimer's disease stages were included. Temporal multilayer networks were used to assess time-varying modular organization. Logistic regression models were employed for disease stage discrimination, and partial least squares analyses examined associations between dynamic measures with cognition and pathology. Temporal multilayer functional measures distinguished all groups, particularly preclinical stages, overcoming the discriminatory power of risk factors such as age, sex, and APOE ϵ4 carriership. Dynamic multilayer functional measures exhibited strong associations with cognition as well as amyloid and tau pathology. Dynamic multilayer functional connectivity shows promise as a functional imaging biomarker for both early- and late-stage Alzheimer's disease diagnosis.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloid beta-PeptidesBrainCognitionHumansMagnetic Resonance ImagingAmyloid beta-PeptidesADcognitionpathologyrs-fMRItemporal brain networks

Identifiers

PMID38212285
PMCPMC10839846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.